Pharmaceutical Supply – Cefazolin Injection (NSN: 6505014802501)

The contract involves the supply of four packages of Cefazolin Injection, a critical pharmaceutical product designated by the National Stock Number 6505014802501, to meet Department of Defense requirements. The vendor is responsible for the complete manufacturing process, including packaging, labeling, and secure delivery, ensuring strict adherence to both FDA regulations and Department of Defense standards for quality, safety, and traceability. The product is intended for military use and must comply with all applicable biologics and pharmaceutical guidelines governing sterility, potency, and labeling accuracy. This is a subcontract under the Defense Logistics Agency, with the North American Industry Classification System code 325412, indicating the focus on pharmaceutical and biological product manufacturing. The contract was posted on July 20, 2026, and the performance location and point of contact details are not specified, but delivery must support the DoD’s operational readiness needs. The award is accessible via the DIBBS system using the provided contract and delivery order identifiers, ensuring transparency and traceability within the federal procurement framework.